Nov 25, 2025 09:25AM Allurion reports 23% weight loss combining balloon therapy with tirzepatide

Nov 20, 2025 09:03AM Allurion Smart Capsule shows 20% weight loss in peer-reviewed study

Nov 18, 2025 09:02AM Allurion partners with ProSurg Medical for Brazil weight loss distribution

Nov 12, 2025 04:21PM Allurion Technologies (ALUR) Misses Q3 EPS by 153c

Oct 3, 2025 04:34PM Allurion board member Alberti-Perez resigns from director role

Aug 14, 2025 10:59AM TD Cowen on Allurion Technologies (ALUR): 'US Approval Is Major Near-Term Catalyst'

Aug 5, 2025 08:06AM Allurion shifts strategy to focus on GLP-1 combination therapy

Jul 22, 2025 08:03AM Allurion reports 95% weight maintenance one year after balloon treatment

Jul 9, 2025 04:06PM Allurion partners with Minogue Medical for Canadian distribution

Jul 7, 2025 08:02AM Allurion submits final PMA module to FDA with supportive study data

May 13, 2025 04:06PM Allurion Technologies (ALUR) Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss

Apr 3, 2025 04:31PM Allurion Technologies (ALUR) Postpones Special Meeting of Stockholders

Apr 3, 2025 09:50AM TD Cowen on Medical Supplies & Devices: 'Companies Least Affected by New Reciprocal Tariffs'

Mar 27, 2025 08:03AM Chardan Capital Markets Reiterates Neutral Rating on Allurion Technologies (ALUR)

Mar 20, 2025 04:05PM Allurion Technologies (ALUR) Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Feb 19, 2025 09:03AM Allurion Technologies (ALUR) to Raise Approximately $6.1M of Gross Proceeds in Offering and Concurrent Private Placement

Feb 18, 2025 08:33AM Allurion Technologies (ALUR) Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Feb 13, 2025 08:30AM Allurion (ALUR) Relaunches in France

Jan 24, 2025 09:30AM Allurion Technologies (ALUR) Announces 1.24M Share Offering at $6/sh

Jan 23, 2025 03:48PM Allurion Technologies (ALUR) Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Jan 21, 2025 08:33AM Allurion Technologies (ALUR) Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Jan 14, 2025 09:20AM Allurion Technologies (ALUR) Announces $2.5M Share Placement, Reports Prelim Q4 Results

Jan 8, 2025 08:00AM Allurion Technologies (ALUR) Announces Positive Topline Results From AUDACITY Trial

Dec 24, 2024 07:00AM Allurion Technologies (ALUR) Announces 1:20 Reverse Share Split

Dec 2, 2024 08:03AM Allurion Technologies (ALUR) Announces Plan to Regain NYSE Compliance

Nov 14, 2024 01:21PM TD Cowen Reiterates Buy Rating on Allurion Technologies (ALUR)

Nov 14, 2024 07:38AM Chardan Capital Markets Downgrades Allurion Technologies (ALUR) to Neutral

Nov 4, 2024 08:12AM Allurion Technologies (ALUR) Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference

Oct 9, 2024 08:03AM Allurion Technologies (ALUR) Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss

Oct 2, 2024 05:56AM TD Cowen Starts Allurion Technologies (ALUR) at Buy

Oct 1, 2024 08:08AM Allurion Technologies (ALUR) Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss

Sep 30, 2024 04:58PM Allurion Technologies (ALUR) Files for 65.21M Share Offering by Selling Stockholders

Sep 6, 2024 03:32AM Roth/MKM Starts Allurion Technologies (ALUR) at Buy

Sep 5, 2024 08:03AM Allurion Technologies (ALUR) Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity

Sep 3, 2024 08:03AM Allurion Technologies (ALUR) Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors

Aug 28, 2024 08:28AM Allurion Technologies (ALUR) Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program

Aug 22, 2024 07:52AM Allurion Technologies (ALUR) PT Lowered to $2.50 at Chardan Capital Markets

Aug 15, 2024 04:06PM Allurion Technologies (ALUR) Receives NYSE Non-compliance Notice

Jul 1, 2024 05:51AM Allurion Technologies (ALUR) Prices $20M Offering at $1.20/sh

Jun 26, 2024 08:36AM Allurion Technologies (ALUR) Launches $20M Share and Warrant Offering

Jun 26, 2024 06:05AM Allurion Technologies (ALUR) Announces $20M Share and Warrant Offering